Stakeholders’ perspectives on a patient-reported outcome measure-based drug safety monitoring system for immune-mediated inflammatory diseases

LJ Kosse; NT Jessurun; HE Vonkeman; SW Tas; MT Nurmohamed; F Hoentjen; Martijn van Doorn; EP van Puijenbroek; BJF Bemt; M Boersma - de Vries

doi:10.1080/14740338.2020.1803826

Stakeholders’ perspectives on a patient-reported outcome measure-based drug safety monitoring system for immune-mediated inflammatory diseases

LJ Kosse, NT Jessurun, HE Vonkeman, SW Tas, MT Nurmohamed, F Hoentjen, Martijn van Doorn, EP van Puijenbroek, BJF Bemt, M Boersma - de Vries

Dermatology

Research output: Contribution to journal › Article › Academic › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	1521-1528
Number of pages	8
Journal	Expert Opinion on Drug Safety
Volume	19
Issue number	11
DOIs	https://doi.org/10.1080/14740338.2020.1803826
Publication status	Published - 2020

Access to Document

10.1080/14740338.2020.1803826

http://hdl.handle.net/1765/129648

Cite this

Kosse, LJ., Jessurun, NT., Vonkeman, HE., Tas, SW., Nurmohamed, MT., Hoentjen, F., van Doorn, M., van Puijenbroek, EP., Bemt, BJF., & Boersma - de Vries, M. (2020). Stakeholders’ perspectives on a patient-reported outcome measure-based drug safety monitoring system for immune-mediated inflammatory diseases. Expert Opinion on Drug Safety, 19(11), 1521-1528. https://doi.org/10.1080/14740338.2020.1803826

@article{e10f189a3ac645258fccc97ff551d3f8,

title = "Stakeholders{\textquoteright} perspectives on a patient-reported outcome measure-based drug safety monitoring system for immune-mediated inflammatory diseases",

author = "LJ Kosse and NT Jessurun and HE Vonkeman and SW Tas and MT Nurmohamed and F Hoentjen and {van Doorn}, Martijn and {van Puijenbroek}, EP and BJF Bemt and {Boersma - de Vries}, M",

year = "2020",

doi = "10.1080/14740338.2020.1803826",

language = "English",

volume = "19",

pages = "1521--1528",

journal = "Expert Opinion on Drug Safety",

issn = "1474-0338",

publisher = "Taylor & Francis Ltd",

number = "11",

}

Kosse, LJ, Jessurun, NT, Vonkeman, HE, Tas, SW, Nurmohamed, MT, Hoentjen, F, van Doorn, M, van Puijenbroek, EP, Bemt, BJF & Boersma - de Vries, M 2020, 'Stakeholders’ perspectives on a patient-reported outcome measure-based drug safety monitoring system for immune-mediated inflammatory diseases', Expert Opinion on Drug Safety, vol. 19, no. 11, pp. 1521-1528. https://doi.org/10.1080/14740338.2020.1803826

TY - JOUR

T1 - Stakeholders’ perspectives on a patient-reported outcome measure-based drug safety monitoring system for immune-mediated inflammatory diseases

AU - Kosse, LJ

AU - Jessurun, NT

AU - Vonkeman, HE

AU - Tas, SW

AU - Nurmohamed, MT

AU - Hoentjen, F

AU - van Doorn, Martijn

AU - van Puijenbroek, EP

AU - Bemt, BJF

AU - Boersma - de Vries, M

PY - 2020

Y1 - 2020

U2 - 10.1080/14740338.2020.1803826

DO - 10.1080/14740338.2020.1803826

M3 - Article

SN - 1474-0338

VL - 19

SP - 1521

EP - 1528

JO - Expert Opinion on Drug Safety

JF - Expert Opinion on Drug Safety

IS - 11

ER -